AbbVie Inc. (ABBV) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for AbbVie Inc. (ABBV): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 57/100 — a percentile rank of AbbVie Inc.’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $459.3B |
| P / E | 73.0× |
| P / S | 7.1× |
| EV / EBITDA | 17.8× |
| Gross margin | 71.5% |
| Operating margin | 25.9% |
| Net margin | 9.8% |
| Return on equity | -106.0% |
| ROIC | 20.7% |
| Revenue growth | 10.4% |
| Debt / equity | -11.9× |
| Dividend yield | 2.6% |
Is AbbVie Inc. overvalued? P/E looks fair vs its 5-year range; P/S looks overvalued vs its 5-year range; EV/EBITDA looks fair vs its 5-year range.
Independent of the events above — derived from AbbVie Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact